New scan could help doctors see if breast cancer drugs are working
NCT ID NCT02608216
Summary
This study is testing a new type of PET/CT scan to see if it can show how breast cancer tumors respond to a combination of two drugs. Researchers want to see if changes on the scan early in treatment can predict how well the patient will do later. The study involves about 20 people with a specific type of metastatic breast cancer who are already scheduled to receive the drug combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.